LifeStance Health Group, Inc. Comprehensive Income
LifeStance Health Group, Inc. (LFST) reported Comprehensive Income of $23.61 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-06
- LifeStance Health Group, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was $23.61M.
- LifeStance Health Group, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was $14.24M, a 3533.42% increase year-over-year.
- LifeStance Health Group, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was $11.67M.
- LifeStance Health Group, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was $732.00K.
- LifeStance Health Group, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was $8.73M.
- LifeStance Health Group, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$58.82M.
- LifeStance Health Group, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$187.23M.
- LifeStance Health Group, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$212.29M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 1 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 4 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23.61M 10-Q · filed 2026-08-06 | $37.85M 10-Q · filed 2026-08-06 | $49.52M derived: sum of 3 quarters · filed 2026-08-06 | $50.26M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $14.24M 10-Q · filed 2026-05-07 | $25.91M derived: sum of 2 quarters · filed 2026-05-07 | $26.64M derived: sum of 3 quarters · filed 2026-05-07 | $22.59M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | $11.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $12.40M derived: sum of 2 quarters · filed 2026-02-25 | $8.34M derived: sum of 3 quarters · filed 2026-08-06 | $8.73M 10-K · filed 2026-02-25 | ||
| 2025-09-30 | $732.00K 10-Q · filed 2025-11-06 | -$3.33M derived: sum of 2 quarters · filed 2026-08-06 | -$2.93M 10-Q · filed 2025-11-06 | -$9.89M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | -$4.06M 10-Q · filed 2026-08-06 | -$3.67M 10-Q · filed 2026-08-06 | -$10.62M derived: sum of 3 quarters · filed 2026-08-06 | -$18.45M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $392.00K 10-Q · filed 2026-05-07 | -$6.56M derived: sum of 2 quarters · filed 2026-05-07 | -$14.39M derived: sum of 3 quarters · filed 2026-05-07 | -$37.91M derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | -$6.95M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$14.78M derived: sum of 2 quarters · filed 2026-02-25 | -$38.30M derived: sum of 3 quarters · filed 2026-02-25 | -$58.82M 10-K · filed 2026-02-25 | ||
| 2024-09-30 | -$7.83M 10-Q · filed 2025-11-06 | -$31.35M derived: sum of 2 quarters · filed 2025-11-06 | -$51.86M 10-Q · filed 2025-11-06 | -$98.90M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2024-06-30 | -$23.52M 10-Q · filed 2025-08-07 | -$44.03M 10-Q · filed 2025-08-07 | -$91.07M derived: sum of 3 quarters · filed 2026-02-25 | -$152.42M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2024-03-31 | -$20.51M 10-Q · filed 2025-05-07 | -$67.55M derived: sum of 2 quarters · filed 2026-02-25 | -$128.90M derived: sum of 3 quarters · filed 2026-02-25 | -$172.24M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2023-12-31 | -$47.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$108.39M derived: sum of 2 quarters · filed 2026-02-25 | -$151.72M derived: sum of 3 quarters · filed 2026-02-25 | -$187.23M 10-K · filed 2026-02-25 | ||
| 2023-09-30 | -$61.35M 10-Q · filed 2024-11-07 | -$104.68M derived: sum of 2 quarters · filed 2024-11-07 | -$140.20M 10-Q · filed 2024-11-07 | -$186.76M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-06-30 | -$43.33M 10-Q · filed 2024-08-08 | -$78.84M 10-Q · filed 2024-08-08 | -$125.41M derived: sum of 3 quarters · filed 2025-02-27 | -$160.08M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-03-31 | -$35.51M 10-Q · filed 2024-05-09 | -$82.08M derived: sum of 2 quarters · filed 2025-02-27 | -$116.75M derived: sum of 3 quarters · filed 2025-02-27 | -$185.47M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2022-12-31 | -$46.57M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$81.23M derived: sum of 2 quarters · filed 2025-02-27 | -$149.96M derived: sum of 3 quarters · filed 2025-02-27 | -$212.29M 10-K · filed 2025-02-27 | ||
| 2022-09-30 | -$34.67M 10-Q · filed 2023-11-08 | -$103.39M derived: sum of 2 quarters · filed 2023-11-08 | -$165.72M 10-Q · filed 2023-11-08 | -$273.75M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-06-30 | -$68.73M 10-Q · filed 2023-08-09 | -$131.06M 10-Q · filed 2023-08-09 | -$239.09M derived: sum of 3 quarters · filed 2024-02-28 | -$359.54M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-03-31 | -$62.33M 10-Q · filed 2023-05-10 | -$170.36M derived: sum of 2 quarters · filed 2024-02-28 | -$290.81M derived: sum of 3 quarters · filed 2024-02-28 | -$360.84M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2021-12-31 | -$108.03M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$228.48M derived: sum of 2 quarters · filed 2024-02-28 | -$298.51M derived: sum of 3 quarters · filed 2024-02-28 | -$307.20M 10-K · filed 2024-02-28 | ||
| 2021-09-30 | -$120.45M 10-Q · filed 2022-11-09 | -$190.49M derived: sum of 2 quarters · filed 2022-11-09 | -$199.17M 10-Q · filed 2022-11-09 | -$204.66M derived: sum of 4 quarters · filed 2023-03-09 | ||
| 2021-06-30 | -$70.03M 10-Q · filed 2022-08-10 | -$78.72M 10-Q · filed 2022-08-10 | -$84.20M derived: sum of 3 quarters · filed 2023-03-09 | -$87.50M derived: sum of 4 quarters · filed 2023-03-09 | ||
| 2021-03-31 | -$8.68M 10-Q · filed 2022-05-11 | -$14.17M derived: sum of 2 quarters · filed 2023-03-09 | -$17.46M derived: sum of 3 quarters · filed 2023-03-09 | -$21.81M derived: sum of 4 quarters · filed 2023-03-09 | ||
| 2020-12-31 | -$5.49M derived: 10-K 9 month − 10-Q 6 month · filed 2023-03-09 | -$8.78M derived: sum of 2 quarters · filed 2023-03-09 | -$13.13M 10-K · filed 2023-03-09 | |||
| 2020-09-30 | -$3.29M 10-Q · filed 2021-11-10 | -$7.64M 10-Q · filed 2021-11-10 | ||||
| 2020-06-30 | -$4.34M 10-Q · filed 2021-08-12 | |||||
| 2020-05-14 | -$27.60M 10-Q · filed 2021-08-12 | -$24.95M 10-K · filed 2023-03-09 | ||||
| 2019-12-31 | $5.67M 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |